Gujarat Kidney & Super Speciality IPO
Gujarat Kidney & Super Speciality IPO is listed on BSE and NSE, priced at ₹108–₹114 per share. The stock debuted at ₹120, delivering a listing gain of 5.3%. The IPO had a lot size of ₹128 shares and a minimum investment of ₹14,592.
Gujarat Kidney & Super Speciality Limited IPO
- IPO Dates
- Dec 22, 2025 – Dec 24, 2025
- Price band
- ₹108-114 per equity share
- Minimum Investment
- ₹14,592
- Issue size
- ₹250.8 Cr
- Lot size
- 128
- Allotment Date
- Dec 26, 2025
- Listing
- Dec 30, 2025
- Listing At
- BSE, NSE
IPO timeline
-
Dec 22, 2025
Open Date
Completed
-
Dec 24, 2025
Close Date
Completed
-
Dec 26, 2025
Allotment Date
Completed
-
Dec 30, 2025
Listing Date
Completed
Price Summary
- Last closing
- 122.62 (7.56%)
- 52 week high
- 126.55
- 52 week low
- 98.36
- Last update
Gujarat Kidney & Super Speciality IPO Subscription Details
View Subscription DetailsGujarat Kidney & Super Speciality IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Gujarat Kidney & Super Speciality IPO Essentials
Gujarat Kidney & Super Speciality IPO Details
Gujarat Kidney & Super Speciality IPO is priced at ₹108-114 per share with a total issue size of 250.8 crore. The IPO has a lot size of 128 shares and is listed on a BSE and NSE.
- Issue price
- ₹108-114 per equity share
- Lot size
- 128 shares
- Face value
- ₹2 Per Equity Share
- Issue size
- 2,20,00,000 shares(aggregating up to ₹250.80 Cr)
- Total issue size
- 2,20,00,000 shares
(aggregating up to ₹250.8 crore) - Fresh issue
- 2,20,00,000 shares
(aggregating up to ₹250.8 crore) - Listing at
- BSE, NSE
- List price
- 120.0(NSE)
- Listing date
- Registrar
- MUFG Intime India Pvt.Ltd.
- Lead manager
-
Nirbhay Capital Services Pvt.Ltd.
Market Lot Size
Investors can bid for a minimum of 128 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 128 | ₹14,592 |
| Retail(max) | 13 | 1,664 | ₹1,89,696 |
| sHNI(min) | 14 | 1,792 | ₹2,04,288 |
| sHNI(max) | 68 | 8,704 | ₹9,92,256 |
| sHNI(min) | 69 | 8,832 | ₹10,06,848 |
Gujarat Kidney & Super Speciality IPO Reservation
Gujarat Kidney & Super Speciality IPO reservation details show category-wise allocation of shares. Out of the total 22000000 shares, approximately 35.12% are reserved for QIB, 15% for NII, 10% for retail investors, and 39.88% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 8773120 (39.88%) | |
| QIB Shares Offered | 7726880 (35.12%) | |
| NII (HNI) Shares Offered | 3300000 (15%) | |
| bHNI > ₹10L | 2200000 (NA%) | 1,228 |
| sHNI < ₹10L | 1100000 (NA%) | 614 |
| Retail Shares Offered | 2200000 (10%) | 17,188 |
| Total Shares Offered | 22000000 (100%) |
Gujarat Kidney & Super Speciality IPO Analytics
Gujarat Kidney & Super Speciality IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Gujarat Kidney & Super Speciality IPO Subscription Status
Gujarat Kidney & Super Speciality IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO is currently subscribed 5.21x, indicating strong demand across investor categories.
| As on | QIB |
NII
bHNI
sHNI
|
Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 77,26,880 |
33,00,000
22,00,000
11,00,000
|
22,00,000 | 1,32,26,880 |
|
Day 1
22-12-25 05:00 PM
|
0.34 x |
1.97x
2.48x
0.96x
|
4.87 x | 1.50 x |
|
Day 2
23-12-25 05:00 PM
|
0.34 x |
2.95x
3.18x
2.48x
|
10.51 x | 2.68 x |
|
Day 3
24-12-25 05:00 PM
|
1.06 x |
5.73x
5.25x
6.68x
|
19.04 x | 5.21 x |
|
Total No. of Applications
|
bHNI | sHNI | Retail |
|---|---|---|---|
| 262553 (Approx) | 1.04x | 5.99x | 14.98x |
Gujarat Kidney & Super Speciality Valuations
Earnings
- EPS Pre IPO
- ₹1.85/-
- EPS Post IPO
- ₹2.74/-
- P/E Pre IPO
- 61.62
- P/E Post IPO
- 41.59
Returns
- ROE
- 36.61%
- ROCE
- 37.65%
- RoNW
- 36.61%
- PAT Margin
- 23.61%
Fundamentals
- Debt / Equity
- 0.15
- Price / Book
- 22.62
- Market Cap
- 898.81 Cr.
Gujarat Kidney & Super Speciality Financials( In Crs.)
| 30-Jun-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|---|
| Assets | 61.59 | 55.34 | 20.53 | 3.87 |
| Revenue | 15.27 | 40.40 | 5.48 | 0.00 |
| Profit After Tax | 5.40 | 9.50 | 1.71 | -0.01 |
| Net Worth | 30.56 | 25.71 | 10.80 | 0.37 |
| Reserves & Surplus | 19.42 | 14.57 | 10.60 | 0.17 |
| Total Borrowing | 4.03 | 3.88 | 1.94 | N/A |
Gujarat Kidney & Super Speciality Company & Offer Insights
About Gujarat Kidney & Super Speciality
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a multispecialty health care service provider engaged in the provision of secondary and tertiary health care services in multiple locations across Gujarat, India.
At the close of business on March 20, 2025, it operates six multispeciality hospitals and three pharmacies, representing a total bed capacity of 400 beds with an approved capacity of 355 beds and an operational capacity of 250 beds.
The hospitals in the company include Gujarat Kidney and Super Speciality Hospital, Vadodara, Gujarat Multispeciality Hospital, Godhra, Raj Palmland Hospital Private Limited, Bharuch, M/s. Surya Hospital and ICU, Borsad, Gujarat Surgical Hospital, Vadodara, and Ashwini Medical Centre, Anand. It also holds a drugstore, Ashwini Medical Store, Anand.
Services:
Secondary Care Services: This refers to both general and surgical treatments.
Tertiary Care Services: Super speciality surgical procedures.
Gujarat Superspeciality Hospital provides medical care in the field of internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology. At March 20, 2025, the company had 322 employees, which include 21 full-time Consultants and 32 visiting consultants. At September 30, 2024, the healthcare professionals of the company comprised 47 doctors and 138 nurses.
Gujarat Kidney & Super Speciality Promoter(s)
Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda, Anitaben Yashwantsinh Bharpoda are the company's promoters of Gujarat Kidney & Super Speciality.
Gujarat Kidney & Super Speciality IPO Issue Objectives
- •
- Proposed acquisition of Parekhs Hospital at Ahmedabad.
- •
- Part-payment of purchase consideration for the already acquired Ashwini Medical Centre
- •
- Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara.
- •
- Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location.
- •
- Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company
- •
- Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda and Anitaben Yashwantsinh Bharpoda
Gujarat Kidney & Super Speciality IPO - Anchor Investors
Gujarat Kidney and Super Speciality rakes in more than Rs 100 crore through anchor book ahead of the IPO.
Craft Emerging Market Fund, through its two sub funds viz. Citadel Capital Fund and Elite Capital Fund is the largest investor in the company's anchor book, subscribing 39.47 lakh shares at Rs 45 crore.
This comes after Khandelwal Finance and Venus Investments picked 13.16 lakh shares for Rs 15 crore, and 8.77 lakh shares for Rs 10 crore, respectively.
Other investors in the anchor book included Nexus Global Opportunities Fund, Arnesta Global Opportunities Fund, Zeta Global Funds, Religo Commodities Ventures Trust, Sunrise Investment Trust, and Innovative Vision Fund, which bought 4.38 lakh shares each for Rs 5 crore in Gujarat Kidney.
Gujarat Kidney & Super Speciality IPO - Peers Comparison
| P/B Ratio | P/E Ratio | RoNW | Revenue(in Cr.) | |
|---|---|---|---|---|
| Gujarat Kidney | N/A | N/A | 36.6% | N/A |
| Yatharth Hospital | 9.3 | 55.8 | 8.1% | 880 |
| Gpt Healthcare | 3.7 | 24.5 | 20.1% | 407 |
| Kmc Speciality | 3.0 | 52.6 | 13.0% | 231 |
Gujarat Kidney & Super Speciality IPO - Strengths and Risks
Gujarat Kidney & Super Speciality IPO strengths and risks highlight key business factors, financial position, and market sentiment that may impact investor interest.
Strengths
Risks
Contact Information
Contact Details
Gujarat Kidney & Super Speciality
+91 265 298 48
info@gujaratsuperspecialityhospital.com
http://www.gujaratsuperspecialityhospital.com/
Plot No. 1, City Sarve No. 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara, Gujarat, India Vadodara, Gujarat, 390020
Registrar Contact Details
Frequently Asked Questions
Click any question to reveal the answer
Gujarat Kidney & Super Speciality IPO is a book-built IPO worth ₹250.8 crore. The price band is ₹108–₹114 per share. The IPO opens on Dec 22, 2025 and closes on Dec 24, 2025. It will be listed on BSE and NSE. MUFG Intime India Pvt. Ltd. is the registrar.
The price band of Gujarat Kidney & Super Speciality IPO is ₹108 to ₹114 per share.
The lot size of Gujarat Kidney & Super Speciality IPO is 128 shares.
The minimum investment for Gujarat Kidney & Super Speciality IPO is approximately ₹14,592 based on the upper price band .
Gujarat Kidney & Super Speciality IPO opens on Dec 22, 2025 and closes on Dec 24, 2025.
The allotment date of Gujarat Kidney & Super Speciality IPO is Dec 26, 2025.
Gujarat Kidney & Super Speciality IPO is expected to be listed on Dec 30, 2025, on BSE and NSE .
Gujarat Kidney & Super Speciality IPO listed on Dec 30, 2025. It was issued at ₹120.0(NSE) and is currently around ₹122.62 as on 30-Apr-2026 3:30 PM, which is approximately 7.6% versus issue price. The 52-week high is ₹126.55.
Based on listing and post-listing performance, Gujarat Kidney & Super Speciality IPO delivered around 7.6% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.
To buy Gujarat Kidney & Super Speciality IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.
Gujarat Kidney & Super Speciality IPO valuation snapshot: P/E 41.59, EPS ₹2.74/-, P/B 22.62, RoNW 36.61%, and market cap 898.81 Cr.
To apply for Gujarat Kidney & Super Speciality IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Gujarat Kidney & Super Speciality IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Gujarat Kidney & Super Speciality IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Gujarat Kidney & Super Speciality IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Gujarat Kidney & Super Speciality IPO allotment status on IPO Ji for quick and easy access.